drugset / Trial / NCT02477852
The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis
Phase 4
Unknown
400 enrolled
Beijing Chest Hospital
Beijing Municipal Science & Technology Commission · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the better preoperative anti-tuberculosis treatment period of patients with spinal tuberculosis.
Timeline
- Start
- 2015-04
- Primary completion
- 2017-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ethambutol | Small molecule | 0.75 g | Oral |
| Subject | Isoniazid | Small molecule | 0.3 g | Oral |
| Subject | Pyrazinamide | Small molecule | 0.5 g | Oral |
| Subject | Rifampin | Small molecule | 0.45 g | Oral |